Skip to search formSkip to main contentSkip to account menu

SCH 27899

Known as: SCH-27899 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

evernimicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis
ABSTRACT Currently, there exist few satisfactory alternatives to vancomycin for therapy of serious methicillin-resistant… 
2001
2001
In Vitro Uptake of SCH 27899 (Evernimicin) by Rat Alveolar Macrophages
ABSTRACT The in vitro uptake of [14C]evernimicin ([14C]SCH 27899) by primary cultures of rat alveolar macrophages and hepatocytes… 
2000
2000
In Vivo Activities of Evernimicin (SCH 27899) against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci in Experimental Endocarditis
ABSTRACT To assess the potential efficacy of evernimicin (SCH 27899) against serious enterococcal infections, we used a rat model… 
2000
2000
High-resolution LC/MS for analysis of minor components in complex mixtures: negative ion ESI for identification of impurities and degradation products of a novel oligosaccharide antibiotic.
High-resolution mass spectrometry has been routinely used for structural confirmation and identification; however, it has mostly… 
2000
2000
In vitro activities of quinupristin/dalfopristin, SCH 27899 (an everninomicin), vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus.
1999
1999
Sch-27899 (Schering-Plough Corp).
  • J. Maertens
  • IDrugs : the investigational drugs journal
  • 1999
  • Corpus ID: 29051621
Sch27899 (Ziracin) is an oligosaccharide antibiotic under development by Schering-Plough as a potential treatment for Gram… 
1999
1999
Sch-27899 (Schering-Plough Corp).
Sch27899 (Ziracin) is an oligosaccharide antibiotic under development by Schering-Plough as a potential treatment for Gram… 
1999
1999
In-vitro activities of 11 antibiotics against vancomycin-resistant enterococci isolated in Japan.
Sir, Since the initial reports of vancomycin-resistant enterococci (VRE) in the late 1980s, increasing numbers of such isolates… 
1999
1999
Simple and sensitive high-performance liquid chromatographic method for the determination of an everninomycin, SCH 27899, in rat plasma.
1995
1995
Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)